CERC-301
Clin301-203
Phase 2 small_molecule completed
Quick answer
CERC-301 for Major Depressive Disorder is a Phase 2 program (small_molecule) at Avalo Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Avalo Therapeutics
- Indication
- Major Depressive Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed